Article
Low-dose Rivaroxaban at Discharge Prevented Some VTE Events at One Month for High-risk Patients Recovering from COVID-19
September 1, 2022
Dr. Thazhatuveetil-Kunhahamed Clinical Question: Is extended rivaroxaban prophylaxis (10 mg daily for 35 days) protective against arterial and venous thromboembolism (VTE) events in COVID-19...
Article
COVID-19 Has Shown the Power of HM
July 1, 2022
Amid the unspeakable tragedies and hardships that the COVID-19 pandemic brought to the medical community are examples of stunning acts of innovation, compassion, and old-fashioned effort. Dr....
Article
Hospitalists Recount the Struggles of Parenting During COVID-19
July 1, 2022
Mary Fredrickson, MD, a hospitalist at HealthPartners and assistant professor of medicine at the University of Minnesota, already had a hectic life before COVID-19, with four children ages 5 to 21,...
Article
Steroid Dosing, Surgery Outcomes for COVID-19 Patients, and More: Highlights from 2021 Research
July 1, 2022
Drs. Frank and Grant did an outstanding job with their in-person In the Literature at SHM Converge. Whether to use a standard or a personalized dose of corticosteroids in hospitalized patients...
Article
Statins should be continued in hospitalized patients with COVID-19
May 2, 2022
Clinical question: Does discontinuation of atorvastatin in those hospitalized with COVID-19 change the risk of mortality and ventilation? Dr. Clark Background: Statins are ubiquitous. Statins...
Article
CPAP reduces the risk of intubation among patients with acute hypoxemic respiratory failure and COVID-19
May 2, 2022
Clinical question: What is the role of continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) compared to conventional oxygen therapy in the management of COVID-19-related acute...
Article
Consider post-discharge VTE prophylaxis for COVID-19 patients
April 1, 2022
Dr. Indovina Clinical question: Should extended post-discharge venous thromboembolism (VTE) prophylaxis be prescribed for patients with COVID-19? Background: While VTE prophylaxis during...
Article
Efficacy of remdesivir in high-risk non-hospitalized patients
April 1, 2022
Dr. Taghvaei Clinical question: Does the use of remdesivir therapy in symptomatic, non-hospitalized, COVID-19 patients reduce disease progression and hospitalization? Background: Remdesivir...
Article
Characteristics of hospitalized patients whose substance use increased amid the impacts of COVID-19
March 3, 2022
Nearly 20 million U.S. adults experience a substance use disorder (SUD) annually,1 leading to more than 650 thousand hospital admissions.2 Large-scale crises like the COVID-19 pandemic can...
Article
It’s time for a change
March 1, 2022
Much has been written about the challenges frontline health care workers have faced during the COVID-19 pandemic. Long hours, excessive death, and fear for one’s own safety and the welfare of...